Table 2.
Descriptive survival statistics
| Stage/score | 3-year, % | 5-year, % | Median, months |
|---|---|---|---|
| Overall | 74 | 52 | 62 |
| Okuda staging system | |||
| A (n= 73) | 75 | 47 | 56 |
| B (n= 228) | 72 | 51 | 63 |
| C (n= 3) | 67 | 67 | – |
| IHPBA staging system | |||
| T1 (n= 69) | 80 | 59 | 82 |
| T2 (n= 284) | 72 | 51 | 61 |
| T3 (n= 26) | 70 | 51 | 62 |
| CLIP score | |||
| 0 (n= 215) | 74 | 51 | 61 |
| 1 (n= 83) | 67 | 47 | 56 |
| 2 (n= 20) | 71 | 47 | 46 |
| 3 (n= 2) | 100 | 100 | 92 |
| BCLC staging system | |||
| 0 (n= 69) | 80 | 59 | 82 |
| A1–A3 (n= 263) | 71 | 50 | 60 |
| A4 (n= 47) | 77 | 55 | 62 |
| JIS score | |||
| 0 (n= 52) | 81 | 65 | 97 |
| 1 (n= 259) | 73 | 49 | 57 |
| 2 (n= 56) | 69 | 57 | 76 |
| 3 (n= 12) | 79 | 47 | 46 |
| AJCC/UICC staging system | |||
| T1 (n= 256) | 80 | 59 | 80 |
| T2 (n= 123) | 59 | 38 | 43 |
| Early HCC prognostic score | |||
| 0 (n= 59) | 87 | 67 | 97 |
| 1 (n= 225) | 78 | 55 | 74 |
| ≥2 (n= 95) | 56 | 37 | 38 |
IHPBA, International Hepato-Pancreato-Biliary Association; CLIP, Cancer of the Liver Italian Programme; BCLC, Barcelona Clinic Liver Cancer; JIS, Japanese Integrated Staging; AJCC/UICC, American Joint Committee on Cancer/International Union Against Cancer, 6th edition; HCC, hepatocellular carcinoma